Related Experiment Video
Updated: Jul 19, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pneumococcal disease surveillance in Europe.
R G Pebody1, W Hellenbrand, F D'Ancona
1Health Protection Agency, London, United Kingdom.
European invasive pneumococcal disease (IPD) surveillance is highly varied, with many countries lacking robust systems. Strengthening surveillance is crucial for informed decisions on pneumococcal conjugate vaccines (PCV).
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Pneumococcal disease (Pnc) causes invasive pneumococcal disease (IPD), a significant public health concern in Europe.
- Several European nations are implementing universal childhood immunization programs with pneumococcal conjugate vaccines (PCV).
Purpose of the Study:
- To assess the current state of national surveillance systems for invasive pneumococcal disease (IPD) across Europe.
- To identify variations and gaps in IPD surveillance methodologies and data collection.
Main Methods:
- A questionnaire survey was distributed to 27 European countries and Norway/Switzerland in 2003, with updates requested in 2006.
- Data on reporting requirements, surveillance systems, case definitions, laboratory practices, and vaccine status collection were analyzed from 22 responding countries.
Main Results:
- IPD surveillance systems were highly heterogeneous across Europe, with four countries lacking reporting requirements.
- Eighteen countries reported 27 national surveillance systems, exhibiting differences in case definitions, serotyping, and susceptibility testing.
- Vaccine status data collection was limited, with only 11/27 systems collecting pneumococcal polysaccharide vaccine status and 5/27 collecting pneumococcal conjugate vaccine status.
Conclusions:
- European surveillance for invasive pneumococcal disease (IPD) is fragmented and inconsistent.
- Strengthening IPD surveillance is essential for effective decision-making regarding new pneumococcal vaccines and monitoring their impact.
Related Concept Videos
Principles of Disease Surveillance
Pneumonia III: Complications and Assessment
Atypical Pneumonia
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

